These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15272899)

  • 1. Prednisolone therapy in Duchenne muscular dystrophy prolongs ambulation and prevents scoliosis.
    Yilmaz O; Karaduman A; Topaloğlu H
    Eur J Neurol; 2004 Aug; 11(8):541-4. PubMed ID: 15272899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors for the development of scoliosis in Duchenne muscular dystrophy.
    Kinali M; Main M; Eliahoo J; Messina S; Knight RK; Lehovsky J; Edge G; Mercuri E; Manzur AY; Muntoni F
    Eur J Paediatr Neurol; 2007 May; 11(3):160-6. PubMed ID: 17257866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid treatment and the development of scoliosis in males with duchenne muscular dystrophy.
    Alman BA; Raza SN; Biggar WD
    J Bone Joint Surg Am; 2004 Mar; 86(3):519-24. PubMed ID: 14996877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols.
    Biggar WD; Politano L; Harris VA; Passamano L; Vajsar J; Alman B; Palladino A; Comi LI; Nigro G
    Neuromuscul Disord; 2004 Sep; 14(8-9):476-82. PubMed ID: 15336688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prednisolone in Duchenne muscular dystrophy with imminent loss of ambulation.
    Pradhan S; Ghosh D; Srivastava NK; Kumar A; Mittal B; Pandey CM; Singh U
    J Neurol; 2006 Oct; 253(10):1309-16. PubMed ID: 16786214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid treatment for the prevention of scoliosis in children with Duchenne muscular dystrophy: long-term follow-up.
    Lebel DE; Corston JA; McAdam LC; Biggar WD; Alman BA
    J Bone Joint Surg Am; 2013 Jun; 95(12):1057-61. PubMed ID: 23783200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up.
    Houde S; Filiatrault M; Fournier A; Dubé J; D'Arcy S; Bérubé D; Brousseau Y; Lapierre G; Vanasse M
    Pediatr Neurol; 2008 Mar; 38(3):200-6. PubMed ID: 18279756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prednisolone in Duchenne muscular dystrophy.
    Rahman MM; Hannan MA; Mondol BA; Bhoumick NB; Haque A
    Bangladesh Med Res Counc Bull; 2001 Apr; 27(1):38-42. PubMed ID: 11692899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of rapidly progressive scoliosis in Duchenne muscular dystrophy by prolongation of walking with orthoses.
    Rodillo EB; Fernandez-Bermejo E; Heckmatt JZ; Dubowitz V
    J Child Neurol; 1988 Oct; 3(4):269-74. PubMed ID: 3198893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional outcomes in Duchenne muscular dystrophy scoliosis: comparison of the differences between surgical and nonsurgical treatment.
    Suk KS; Lee BH; Lee HM; Moon SH; Choi YC; Shin DE; Ha JW; Song KM; Kim HS
    J Bone Joint Surg Am; 2014 Mar; 96(5):409-15. PubMed ID: 24599203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scoliosis in Duchenne muscular dystrophy (DMD).
    Hsu JD; Quinlivan R
    Neuromuscul Disord; 2013 Aug; 23(8):611-7. PubMed ID: 23746543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy.
    King WM; Ruttencutter R; Nagaraja HN; Matkovic V; Landoll J; Hoyle C; Mendell JR; Kissel JT
    Neurology; 2007 May; 68(19):1607-13. PubMed ID: 17485648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroid therapy for duchenne muscular dystrophy: improvement of psychomotor function.
    Sato Y; Yamauchi A; Urano M; Kondo E; Saito K
    Pediatr Neurol; 2014 Jan; 50(1):31-7. PubMed ID: 24138948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tranexamic acid diminishes intraoperative blood loss and transfusion in spinal fusions for duchenne muscular dystrophy scoliosis.
    Shapiro F; Zurakowski D; Sethna NF
    Spine (Phila Pa 1976); 2007 Sep; 32(20):2278-83. PubMed ID: 17873823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prednisolone treatment for Duchenne muscular dystrophy].
    Shimomura H; Fujii T; Miyajima T; Kumada T; Kimura N; Oda N; Saito K
    No To Hattatsu; 2011 Jan; 43(1):24-9. PubMed ID: 21400928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prednisolone improves walking in Japanese Duchenne muscular dystrophy patients.
    Takeuchi F; Yonemoto N; Nakamura H; Shimizu R; Komaki H; Mori-Yoshimura M; Hayashi YK; Nishino I; Kawai M; Kimura E; Takeda S
    J Neurol; 2013 Dec; 260(12):3023-9. PubMed ID: 24057148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scoliosis in Duchenne muscular dystrophy children is fully reducible in the initial stage, and becomes structural over time.
    Choi YA; Shin HI; Shin HI
    BMC Musculoskelet Disord; 2019 Jun; 20(1):277. PubMed ID: 31170965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy.
    McDonald CM; Henricson EK; Han JJ; Abresch RT; Nicorici A; Elfring GL; Atkinson L; Reha A; Hirawat S; Miller LL
    Muscle Nerve; 2010 Apr; 41(4):500-10. PubMed ID: 19941337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-surgical prevention and management of scoliosis for children with Duchenne muscular dystrophy: what is the evidence?
    Harvey A; Baker L; Williams K
    J Paediatr Child Health; 2014 Oct; 50(10):E3-9. PubMed ID: 23560735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of steroid therapy for Duchenne muscular dystrophy in Japan.
    Goto M; Komaki H; Takeshita E; Abe Y; Ishiyama A; Sugai K; Sasaki M; Goto Y; Nonaka I
    Brain Dev; 2016 Oct; 38(9):785-91. PubMed ID: 27112384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.